Challenges in developing evidence-based drug dosing guidelines for adults and children receiving renal replacement therapy

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 5, 2009, Pages 479-482

  Mueller, B A ^a   Smoyer, W E ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ACUTE KIDNEY FAILURE; ARTIFICIAL KIDNEY; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG MONITORING; GRAM POSITIVE INFECTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HOSPITALIZED CHILD; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; PATIENT SAFETY; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RENAL REPLACEMENT THERAPY; SHORT SURVEY; ULTRAFILTRATION;

ACUTE KIDNEY INJURY; ADULT; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY FAILURE, CHRONIC; PHARMACEUTICAL PREPARATIONS; PRACTICE GUIDELINES AS TOPIC; RENAL REPLACEMENT THERAPY; RESEARCH DESIGN;

EID: 70350224115     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.150     Document Type: Short Survey

References (13)

1. Manley, H.J. et al. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol. Dial. Transplant. 19, 1842-1848 (2004).
2. Dreisbach, A.W. & Lertora, J.J. The effect of chronic renal failure on drug metabolism and transport. Expert Opin. Drug Metab. Toxicol. 4, 1065-1074 (2008).
3. Manley, H.J., Cannella, C.A., Bailie, G.R. & St Peter, W.L. Medication-related problems in ambulatory hemodialysis patients: a pooled analysis. Am. J. Kidney Dis. 46, 669-680 (2005).
4. US Food and Drug Administration. Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function-Study Design, Data Analysis and Impact on Dosing and Labeling (14 May 1998).
5. Vancomycin hydrochloride (vancomycin hydrochloride for injection) [package insert]. Lake Forest, IL: Hospira
6. Aronoff, G.R. et al. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children (Philadelphia, PA: American College of Physicians, 2007).
7. US Food and Drug Administration. Preliminary Concept Paper: Pharmacokinetics in Patients with Impaired Renal Function-Study Design, Data Analysis and Impact on Dosing and Labeling (19 March 2008).
8. National Kidney Foundation-Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am. J. Kidney Dis. 48 (suppl. 1), S2-S90 (2006).
9. Ronco, C. et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356, 26-30 (2000).
10. Palevsky, P.M., et al. Intensity of renal support in critically ill patients with acute kidney injury. N. Engl. J. Med. 359, 7-20 (2008).
11. Teraoka, T. et al. Prediction of iopromide reduction rates during haemodialysis using an in vitro dialysis system. Nephrol. Dial. Transplant. 20, 754-759 (2005).
12. Stevenson, J.M. et al. Ertapenem clearance during modeled continuous renal replacement therapy. Int. J. Artif. Organs 31, 1027-1034 (2008).
13. Churchwell, M.D., Pasko, D.A., Btaiche, I.F., Jain, J.C. & Mueller, B.A. Trace element removal during in vitro and in vivo continuous haemodialysis. Nephrol. Dial. Transplant. 22, 2970-2977 (2007).